Join to View Full Profile
9200 W Wisconsin Ave# DivisionMilwaukee, WI 53226
Phone+1 414-805-6800
Fax+1 414-805-4944
Dr. Chitambar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 1980 - 1983
University of Texas at Austin Dell Medical SchoolResidency, Internal Medicine, 1978 - 1980- University of Texas at Austin Dell Medical SchoolInternship, Transitional Year, 1977 - 1978
Christian Medical College LudhianaClass of 1976
Certifications & Licensure
WI State Medical License 1984 - 2025
IA State Medical License 1979 - 2016
CO State Medical License 1980 - 1989
TX State Medical License 1980 - 1988
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2004-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsStay on Track: A Pilot Randomized Control Trial on the Feasibility of a Diet and Exercise Intervention in Patients with Breast Cancer Receiving Radiotherapy.Gopika SenthilKumar, Aronne M Schottstaedt, Lindsay L Peterson, Lauren N Pedersen, Christopher R Chitambar
Cancer Research Communications. 2024-05-07 - Divergent Cellular Expression Patterns of PD-L1 and PD-L2 Proteins in Breast Cancer.Julie M Jorns, Yunguang Sun, Sailaja Kamaraju, Yee Chung Cheng, Amanda Kong
Journal of Personalized Medicine. 2024-04-29 - Matched Case Control Analysis of Breast Cancer- Specific Factors Affecting Risk of Developing SARS-CoV-2 Infection.Michael Pierro, Joanna Zurko, Anika Szabo, Yee Chung Cheng, Sailaja Kamaraju
WMJ. 2023-12-01
Press Mentions
Imaging Biometrics Shares Promising Phase 1 Clinical Trial Results and Plans for Phase 2June 19th, 2024- Glioblastoma Clinical Trial Studying New Therapy Gallium Maltolate (GaM)April 12th, 2022
- Innovative Therapy That “Tricks” and Destroys Cancer Cells Advances to Clinical TrialApril 8th, 2022
- Join now to see all
Grant Support
- Cellular Targets For Gallium Compounds In LymphomaNational Cancer Institute2005–2008
- Gallium--Antineoplastic Activity And Drug ResistanceNational Cancer Institute1995–1997
- Cellular Uptake And Interaction Of Iron And GalliumNational Cancer Institute1988–1992
- Cellular Uptake And Interaction Of Iron And GalliumNational Cancer Institute1986–1988
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
